StockData
OneMedNet Corp logo

OneMedNet Corp (ONMD) company profile

ONMDNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as ONMDW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$4.95+0.09 (+1.85%)

Close on Nov 17, 2026Market cap $293.47MP/E –Yield –

About OneMedNet

Services-Commercial Physical & Biological Research, SIC 8731

OneMedNet Corporation operates within healthcare technology, specializing in clinical image exchange and regulatory-grade real-world data management. The company generates revenue primarily through subscription services and specialized data delivery offerings. Through its platform and solutions, OneMedNet connects healthcare providers, life science organizations, and academic medical researchers to securely access, transmit, and analyze clinical data. Its technological framework facilitates data interoperability across disparate systems while maintaining rigorous compliance with medical data privacy and regulatory frameworks.

The company conducts commercial activities across North America, Europe, the Middle East, and the Asia-Pacific region. Its operations encompass customer contracts and partner networks spanning multiple regional markets. OneMedNet Corporation maintains its principal executive offices in Eden Prairie, Minnesota.

Summary of the business section of OneMedNet's latest annual report, written by StockData.

Company profile

Company

Legal name
OneMedNet Corp
Headquarters
Surrey, X0
Address
Trident Court, 1 Oakcroft Road, Chessington KT9 1BD
Phone
011-44-208-090-2009
Employees
23, Dec 31, 2025
Industry
Services-Commercial Physical & Biological Research
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
WithumSmith+Brown, PC, East Brunswick, New Jersey

Stock & identifiers

Ticker
ONMD
Other tickers
ONMDW
Former tickers
DKDC until Nov 13, 2023
Exchange
Nasdaq
IPO date
May 10, 2021
Shares outstanding
59M, Aug 11, 2026
Public float
$13.80M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Stock splits
1-for-10 reverse, Sep 29, 2026
SEC CIK
1849380
CUSIP
68270C103
ISIN
US68270C1036
FIGI
BBG00ZLKW5Y0
Share class FIGI
BBG00ZLKW6S5
EIN
86-2076743

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Jeffrey YuChief Medical Officer, Director1,028,037
Aaron GreenChief Executive Officer, Director247,971
Robert Lawrence GoldenChief Financial Officer, Director91,291
Thomas KosasaDirector1,983,573
Kenneth AlleyneDirector38,219
Andrew B. ZeinfeldDirector381,525
Sherry Coonse McCrawDirector56,342
Eric CasaburiDirector110,475
Jair ClarkeDirector138,485

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsOption awardsTotalvs. prior year
Aaron Green
President and Chief Executive Officer
$350.00K$757.62K–$757.62K+194%
Robert Golden
Chief Financial Officer
–$329.67K$169.00K$498.67K+230%
Dr. Jeffrey Yu
Founder, Chief Medical Officer, Vice President, Chairman of the Board of Directors
$300.00K$237.85K–$537.85K+68%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
May 10, 2021
Offer price
$10.00
Securities offered
10,000,000
Gross proceeds
$100.00M
Exchange
Nasdaq
First trading day
Jun 24, 2021
First-day close
$9.90-1.0%
Lock-up ends (est.)
Dec 21, 2021

“Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one redeemable warrant as described in more detail in this prospectus.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“workforce is comprised of approximately 23 employees (as of December 31, 2025), including approximately 1 part-time employee (references”

Corporate history

Events identified from SEC filings

DateEventDetails
Apr 20, 2026Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Apr 15, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Apr 1, 2025Late filingNotification of late filing
Mar 14, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Nov 27, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Nov 15, 2024Late filingNotification of late filing
Oct 17, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Oct 15, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Sep 12, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 16, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jun 24, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jun 14, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jun 4, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
May 14, 2024Late filingNotification of late filing
May 10, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 1, 2024Late filingNotification of late filing
Mar 29, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Feb 9, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jan 3, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
Nov 14, 2023Late filingNotification of late filing
Nov 13, 2023Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Nov 7, 2023Name changeName changed from Data Knights Acquisition Corp. to OneMedNet Corp
Nov 7, 2023DelistingNotice of delisting from exchange (Form 25)
May 15, 2023Late filingNotification of late filing
Nov 14, 2022Late filingNotification of late filing
Jul 22, 2022MergerRegistration of securities for a merger or exchange offer (S-4)
Mar 31, 2022Late filingNotification of late filing
May 10, 2021IPOInitial public offering priced (424B4 prospectus)
May 5, 2021ListingRegistration of securities on an exchange (Form 8-A)

See a number that looks wrong?